BioCentury
ARTICLE | Company News

Nuevolution, Novartis deal

September 7, 2009 7:00 AM UTC

Nuevolution will use its Chemetics drug discovery technology to identify small molecules against undisclosed targets from Novartis. Nuevolution will screen its Chemetics fragment-based library and the...